Repligen (RGEN)
(Real Time Quote from BATS)
$166.90 USD
+1.24 (0.75%)
Updated Apr 26, 2024 03:26 PM ET
4-Sell of 5 4
F Value D Growth C Momentum F VGM
Income Statements
Fiscal Year end for Repligen Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 639 | 802 | 671 | 366 | 270 |
Cost Of Goods | 354 | 346 | 279 | 157 | 119 |
Gross Profit | 285 | 456 | 391 | 210 | 151 |
Selling & Adminstrative & Depr. & Amort Expenses | 230 | 231 | 224 | 140 | 115 |
Income After Depreciation & Amortization | 55 | 225 | 167 | 70 | 36 |
Non-Operating Income | 12 | -4 | -1 | 2 | -1 |
Interest Expense | 2 | 1 | 13 | 12 | 9 |
Pretax Income | 64 | 219 | 154 | 59 | 26 |
Income Taxes | 23 | 33 | 25 | -1 | 5 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 42 | 186 | 128 | 60 | 21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 42 | 186 | 128 | 60 | 21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 125 | 277 | 217 | 108 | 57 |
Depreciation & Amortization (Cash Flow) | 71 | 53 | 50 | 38 | 21 |
Income After Depreciation & Amortization | 55 | 225 | 167 | 70 | 36 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 56.38 | 57.46 | 57.26 | 53.89 | 49.21 |
Diluted EPS Before Non-Recurring Items | 1.75 | 3.28 | 3.06 | 1.65 | 1.07 |
Diluted Net EPS (GAAP) | 0.74 | 3.24 | 2.24 | 1.11 | 0.44 |
Fiscal Year end for Repligen Corporation falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 155.74 | 141.19 | 159.17 | 182.66 |
Cost Of Goods | NA | 88.14 | 104.63 | 79.31 | 81.85 |
Gross Profit | NA | 67.61 | 36.56 | 79.86 | 100.82 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 68.50 | 31.75 | 60.47 | 69.56 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -0.89 | 4.81 | 19.39 | 31.26 |
Non-Operating Income | NA | -6.73 | 7.10 | 6.04 | 5.11 |
Interest Expense | NA | 1.14 | 0.27 | 0.27 | 0.27 |
Pretax Income | NA | -8.76 | 11.64 | 25.16 | 36.09 |
Income Taxes | NA | 16.73 | -6.54 | 5.10 | 7.26 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -25.49 | 18.17 | 20.06 | 28.83 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -25.49 | 18.17 | 20.06 | 28.83 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 55.82 | 56.94 | 56.86 | 57.05 |
Diluted EPS Before Non-Recurring Items | NA | 0.33 | 0.23 | 0.53 | 0.64 |
Diluted Net EPS (GAAP) | NA | -0.44 | 0.32 | 0.35 | 0.51 |